- £1.15bn
- £1.17bn
- £432.10m
- 99
- 52
- 52
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 388 | 345 | 317 | 388 | 432 |
Cost of Revenue | |||||
Gross Profit | 266 | 230 | 223 | 263 | 292 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 270 | 258 | 243 | 299 | 335 |
Operating Profit | 118 | 87 | 73.4 | 89 | 97.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 116 | 87.8 | 70.2 | 85.2 | 92.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 94.9 | 69.3 | 52.1 | 69.3 | 72.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 94.9 | 69.3 | 52.7 | 68.3 | 72.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 94.9 | 69.3 | 52.7 | 68.3 | 72.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.18 | 0.129 | 0.103 | 0.127 | 0.135 |
Dividends per Share | |||||
Special Dividends per Share |